Protecting effects of intravenous insoluble glycogen treatment on the experimental necrotizing acute pancreatitis of dogs

Hepato-Gastroenterology

Volumn 44, Issue 13, 1997, Pages 127-132

  Sipka, S ^a   Sapy, P ^a   Bot, Gy ^a   Furka, I ^a   Miko I ^a   Arkossy P ^a   Dauda, Gy ^a   Szappanos, M ^a   Kovacs, J ^a   Lakos, G ^a   Szegedi, Gy ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Insoluble glycogen; Necrotizing acute pancreatitis

Indexed keywords

AMYLASE; ENDOTOXIN; GLYCOGEN; OLIVE OIL; PHOSPHOLIPASE A; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOG; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; NONHUMAN; PANCREAS DUCT; PRIORITY JOURNAL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

AMYLASES; ANIMALS; DOGS; FEMALE; GLYCOGEN; INJECTIONS, INTRAVENOUS; LIPASE; MALE; PANCREATITIS, ACUTE NECROTIZING; PHOSPHOLIPASES A; SOLUBILITY;

EID: 8044227211     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Fitz RH: Acute pancreatitis: A consideration of acute hemorrhage, hemorrhagic: suppurative and gangrenous pancreatitis and of disseminated fat necrosis. Boston Med. Surg. J. 1889; 120: 181-187.
2. Malfertheiner P, Kemmer TP: Clinical picture and diagnosis of acute pancreatitis. Hepato-gastroenterology 1991; 38: 97-100.
3. 2 in acute pancreatitis. In: Beger, H. G, Büchler, M. (eds.) Acute pancreatitis - Research and clinical management Springer Press, Berlin - Heidelberg - New York - London - Paris - Tokyo (1987) pp.71-78
4. Beger HG, Bittner R, Block S, Büchler M: Bacterial contamination of pancreatic necrosis: A prospective clinical study. Gastro-enterology 1986; 91: 433-438.
5. Sipka S, Bot Gy, Gergely P, Bertok L, Csongor J, Sαpy P, Szappanos M, Duda E, Szegedi Gy: Insoluble glycogen, a metabolizable internal absorbentn decreases the lethality of endotoxin shock in rats. (Submitted for publication).
6. Farkas I, Toth B, Gergely P, Bot Gy: Insoluble glycogen and its interaction with phosphorylase. A novel method for the purification of liver phosphorylase A. Acta Biochim. Biophys. Hung. 1987; 22: 17-29.
7. 2 induced by interactions of human platelets with monocytes. Ann. Hemato 1994; 169: 307-310.
8. Dobosz M, Sledzinski, Juszkiewicz P, Babicki A, Stanek A, Wajda Z, Basinski A: Beneficial effect of therapeutic infusion of Nafamostat Mesilate (FUT-175) on hemodynamics in experimental Acute Pancreatitis. Hepato-Gastroenterol. 1991; 38: 139-142.
9. Lilja J, Dimberg J, Sjωdahl R, Tagesson C, Gustafson-Svδrd C: Effects of endotoxine and dexamethasone on group I and II phospholipae A2 in rat ileum and stomach. Gut 1994; 35: 40-45.
10. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 1992; 20: 864-874.
11. Bende S, Bertok L: Elimination of endotoxin from the blood by extracorporeal activated charcoal hemoperfusion in experimental canine endotoxin shock. Circ. Shock 1986; 19: 239-244.
12. Gardiner KR, Anderson NH, McCaigue MD, Erwin PJ, Halliday MI, Rowlands BJ: Adsorbents as antiendotoxin agents in experimantal colitis. Gut 1993; 34: 51-55.
13. Watson RCW, Redmont HP, Bouchier-Hayes D: Role of endotoxin in mononuclear phagocyte-mediated inflammatory responses. J. Leuk. Biol. 1994; 56: 95-103.
14. Gijoσn MA, Pirez C, Mindez K, Sanches Crespo M: Phospholipase A2 from plasma of patients with septic shock is associated with high-density lipoproteins and C3 anaphylatoxin: some implications for its functional role. Biochem. J. 1995; 306: 167-175.
15. Hewett JA, Roth RA: Hepatic and Extrahepatic Pathobiology of Bacterial Lipopolysaccharides. Pharm. Rev. 1993; 45: 381-411.